Abstract | OBJECTIVE: STUDY DESIGN: Clinical report. ANIMALS: A 3.5-month-old male whooping crane (Grus americana). METHODS: An open, severely comminuted humeral facture was stabilized with an intramuscular (IM) pin/type IA external skeletal fixator with tie-in configuration. rhBMP-2 was applied in a calcium phosphate matrix (CPM) paste directly to the fracture site as a bone graft substitute. Radiographic evidence of bone healing was monitored for 14 weeks. RESULTS: Substantial bony callus was evident at 4 weeks and at 8 weeks there was bridging callus with obvious bony remodeling. The fixation was destabilized at 9 weeks by IM pin removal, bone healing progressed and the fixator was removed at 11 weeks. By 14 weeks both cortices had been re-established with continued callus remodeling evident. CONCLUSION: rhBMP-2, applied in a CPM paste, was used as a bone graft substitute in the treatment of a comminuted, open humeral fracture in a whooping crane. CLINICAL RELEVANCE: Use of rhBMP-2/CPM should be considered in treatment of avian fractures.
|
Authors | Susannah Sample, Gretchen Cole, Joanne Paul-Murphy, Barry K Hartup, Victoria Clyde, Howard J Seeherman, Susan Schaefer |
Journal | Veterinary surgery : VS
(Vet Surg)
Vol. 37
Issue 6
Pg. 552-7
(Aug 2008)
ISSN: 1532-950X [Electronic] United States |
PMID | 19134105
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Bone Morphogenetic Protein 2
- Bone Morphogenetic Proteins
- Calcium Phosphates
- Recombinant Proteins
- Transforming Growth Factor beta
- recombinant human bone morphogenetic protein-2
|
Topics |
- Animals
- Animals, Wild
- Birds
(injuries, surgery)
- Bone Morphogenetic Protein 2
- Bone Morphogenetic Proteins
(therapeutic use)
- Bony Callus
(drug effects, physiology)
- Calcium Phosphates
- Fracture Fixation, Internal
(instrumentation, methods, veterinary)
- Fracture Healing
(drug effects, physiology)
- Fractures, Bone
(surgery)
- Fractures, Comminuted
(surgery)
- Humeral Fractures
(surgery, veterinary)
- Male
- Recombinant Proteins
(therapeutic use)
- Transforming Growth Factor beta
(therapeutic use)
- Treatment Outcome
|